Pharmaceutical Products under Section 301
QUESTION: Will pharmaceutical products made in China and included in the Pharmaceutical Appendix to the Harmonized Tariff schedule, remain free of duty upon entry into the USA under special preference program K, and not be effected by the proposed 10% additional duty recently levied by Section 301? ========== Answers: No, Section 301 duties are additional. […]